Sudden cardiac death laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
*An elevated concentration of [[brain natriuretic peptide]]([[BNP]]) or [[N-terminal pro-b-type-natriuretic peptide]] has been shown to have roles in the [[SCD]] risk determination of [[patients]] <ref name="ScottBarry2009">{{cite journal|last1=Scott|first1=Paul A.|last2=Barry|first2=James|last3=Roberts|first3=Paul R.|last4=Morgan|first4=John M.|title=Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis|journal=European Journal of Heart Failure|volume=11|issue=10|year=2009|pages=958–966|issn=13889842|doi=10.1093/eurjhf/hfp123}}</ref> <ref name="pmid21044699">{{cite journal| author=Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA| title=N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. | journal=Heart Rhythm | year= 2011 | volume= 8 | issue= 2 | pages= 228-33 | pmid=21044699 | doi=10.1016/j.hrthm.2010.10.038 | pmc=3826546 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21044699 }} </ref> <ref name="pmid32700639">{{cite journal| author=Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM| title=Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death. | journal=Circulation | year= 2020 | volume= 142 | issue= 12 | pages= 1148-1158 | pmid=32700639 | doi=10.1161/CIRCULATIONAHA.120.046947 | pmc=7995996 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32700639 }} </ref> <ref name="pmid12021226">{{cite journal| author=Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B | display-authors=etal| title=B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. | journal=Circulation | year= 2002 | volume= 105 | issue= 20 | pages= 2392-7 | pmid=12021226 | doi=10.1161/01.cir.0000016642.15031.34 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12021226 }} </ref>. | *An elevated concentration of [[brain natriuretic peptide]]([[BNP]]) or [[N-terminal pro-b-type-natriuretic peptide]] has been shown to have roles in the [[SCD]] risk determination of [[patients]] <ref name="ScottBarry2009">{{cite journal|last1=Scott|first1=Paul A.|last2=Barry|first2=James|last3=Roberts|first3=Paul R.|last4=Morgan|first4=John M.|title=Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis|journal=European Journal of Heart Failure|volume=11|issue=10|year=2009|pages=958–966|issn=13889842|doi=10.1093/eurjhf/hfp123}}</ref> <ref name="pmid21044699">{{cite journal| author=Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA| title=N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. | journal=Heart Rhythm | year= 2011 | volume= 8 | issue= 2 | pages= 228-33 | pmid=21044699 | doi=10.1016/j.hrthm.2010.10.038 | pmc=3826546 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21044699 }} </ref> <ref name="pmid32700639">{{cite journal| author=Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM| title=Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death. | journal=Circulation | year= 2020 | volume= 142 | issue= 12 | pages= 1148-1158 | pmid=32700639 | doi=10.1161/CIRCULATIONAHA.120.046947 | pmc=7995996 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32700639 }} </ref> <ref name="pmid12021226">{{cite journal| author=Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B | display-authors=etal| title=B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. | journal=Circulation | year= 2002 | volume= 105 | issue= 20 | pages= 2392-7 | pmid=12021226 | doi=10.1161/01.cir.0000016642.15031.34 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12021226 }} </ref>. | ||
*However, there is still a lack of sufficient evidence on the use of [[BNP]] as a method in the selection for the need of an [[implantable cardioverter defibrillators]] ([[ICD]]) <ref name="pmid19789399">{{cite journal| author=Scott PA, Barry J, Roberts PR, Morgan JM| title=Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. | journal=Eur J Heart Fail | year= 2009 | volume= 11 | issue= 10 | pages= 958-66 | pmid=19789399 | doi=10.1093/eurjhf/hfp123 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19789399 }} </ref> <ref name="pmid24952693">{{cite journal| author=Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE | display-authors=etal| title=Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. | journal=JACC Heart Fail | year= 2014 | volume= 2 | issue= 3 | pages= 260-8 | pmid=24952693 | doi=10.1016/j.jchf.2013.12.004 | pmc=4224312 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24952693 }} </ref>. | *However, there is still a lack of sufficient evidence on the use of [[BNP]] as a method in the selection for the need of an [[implantable cardioverter defibrillators]] ([[ICD]]) <ref name="pmid19789399">{{cite journal| author=Scott PA, Barry J, Roberts PR, Morgan JM| title=Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. | journal=Eur J Heart Fail | year= 2009 | volume= 11 | issue= 10 | pages= 958-66 | pmid=19789399 | doi=10.1093/eurjhf/hfp123 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19789399 }} </ref> <ref name="pmid24952693">{{cite journal| author=Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE | display-authors=etal| title=Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. | journal=JACC Heart Fail | year= 2014 | volume= 2 | issue= 3 | pages= 260-8 | pmid=24952693 | doi=10.1016/j.jchf.2013.12.004 | pmc=4224312 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24952693 }} </ref>. | ||
==References== | ==References== | ||
Revision as of 21:14, 19 July 2023
|
Sudden cardiac death Microchapters |
|
Diagnosis |
|---|
|
Sudden cardiac death laboratory findings On the Web |
|
American Roentgen Ray Society Images of Sudden cardiac death laboratory findings |
|
Risk calculators and risk factors for Sudden cardiac death laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]
Overview
Brain natriuretic peptide (BNP) or N-terminal pro-b-type-natriuretic peptide may have roles in the risk determination of patients for ventricular arrhythmia and sudden cardiac death.
Laboratory Findings
- An elevated concentration of brain natriuretic peptide(BNP) or N-terminal pro-b-type-natriuretic peptide has been shown to have roles in the SCD risk determination of patients [1] [2] [3] [4].
- However, there is still a lack of sufficient evidence on the use of BNP as a method in the selection for the need of an implantable cardioverter defibrillators (ICD) [5] [6].
References
- ↑ Scott, Paul A.; Barry, James; Roberts, Paul R.; Morgan, John M. (2009). "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis". European Journal of Heart Failure. 11 (10): 958–966. doi:10.1093/eurjhf/hfp123. ISSN 1388-9842.
- ↑ Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA (2011). "N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study". Heart Rhythm. 8 (2): 228–33. doi:10.1016/j.hrthm.2010.10.038. PMC 3826546. PMID 21044699.
- ↑ Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM (2020). "Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death". Circulation. 142 (12): 1148–1158. doi:10.1161/CIRCULATIONAHA.120.046947. PMC 7995996 Check
|pmc=value (help). PMID 32700639 Check|pmid=value (help). - ↑ Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B; et al. (2002). "B-type natriuretic peptide predicts sudden death in patients with chronic heart failure". Circulation. 105 (20): 2392–7. doi:10.1161/01.cir.0000016642.15031.34. PMID 12021226.
- ↑ Scott PA, Barry J, Roberts PR, Morgan JM (2009). "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis". Eur J Heart Fail. 11 (10): 958–66. doi:10.1093/eurjhf/hfp123. PMID 19789399.
- ↑ Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE; et al. (2014). "Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure". JACC Heart Fail. 2 (3): 260–8. doi:10.1016/j.jchf.2013.12.004. PMC 4224312. PMID 24952693.